健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion

Sponsor:
Collaborators:
Information provided by (Responsible Party):
Amr Hatem Ahmed Mohammed,Assiut University
September 28, 2018
October 2, 2018
October 2, 2018
November 2018
November 2020   (Final data collection date for primary outcome measure)
Oswestry Disability index(Arabic version) 1 month[ Time Frame: 1 month ]
an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.

Same as current
  • • Fusion rate as assessed by Bridwell fusion score.[ Time Frame: 1 year ]
    Grade I is defined as fusion with remodelling and trabeculae present; Grade II is an intact graft with incomplete remodelling and no lucency present; Grade III is an intact graft with potential lucency at the cranial or caudal end; Grade IV is absent fusion with collapse/resorption of the graft.
 

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion

A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure.

The first randomized controlled trial comparing minimally invasive TLIF and open TLIF.
Interventional
N/A
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Masking: Interventional
Masking Description:
Primary Purpose: Treatment
  • Procedure: Transforaminal Lumbar Interbody Fusion either open or minimally invasive
    Spinal fusion procedure through the intervertebral foramen
  • Other: O-TLIF group
    Spinal fusion ,Transforaminal lumbar interbody fusion procedure will be performed through open surgery.
  • Other: MI-TLIF group
    Spinal fusion,Transforaminal lumbar interbody fusion procedure will be performed through minimally invasive surgery using a tubular retractor.
 
Not yet recruiting
60
Same as current
October 2021
November 2020   (Final data collection date for primary outcome measure)
Inclusion Criteria: - Adults more than 18 years of age and less than 65 years of age.. - Degenerative or isthmic spondylolithesis Grade 1,2 and 3. - Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression. - Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1. - Symptoms not responding to conservative treatment for at least 3 months. Exclusion Criteria: - Previous spinal fusion or instrumentation. - Spinal tumours, infection and fractures. - Patients with severe osteoporosis - BMI more than 35. - Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome) - Patients not willing to participate in the study
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
 
 
Yes
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Amr Hatem Ahmed Mohammed,Assiut University
Assiut University
:
Assiut University
September 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
请使用微信扫码报名